PATTI WALTERS: Open Payments
NPI 1851569131 · BRAZIL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 44 payments from 18 companies in 2025. Trend: 2023 $14 · 2024 $571 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $165 |
| Lilly USA, LLC | 10 | $149 |
| Corcept Therapeutics | 4 | $92 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Amgen Inc. | 3 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Boston Scientific Corporation | 1 | $26 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Abbott Laboratories | 1 | $22 |
Products named: JARDIANCE, Korlym, MOUNJARO, Ozempic, TRELEGY ELLIPTA, Wegovy, OTEZLA, JOURNAVX.
Industry payments across IN — which companies pay providers there.
